HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and Zimbabwe. by Jaganath, D, Walker, A, Ssali, F, Musiime, V, Kiweewa, F, Kityo, C, Salata, R, Mugyenyi, P

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe. by Muyingo, S, Walker, A, Reid, A, Munderi, P, Gibb, D, Ssali, F, Levin, J, Katabira, E, Gilks, C, Todd, J

Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy. by Kikaire, B, Khoo, S, Walker, A, Ssali, F, Munderi, P, Namale, L, Reid, A, Gibb, D, Mugyenyi, P, Grosskurth, H

Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DART. by Munderi, P, Snowden, W, Walker, A, Kityo, C, Mosteller, M, Kabuye, G, Thoofer, N, Ssali, F, Gilks, C, Hughes, A

Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa. by Stöhr, W, Reid, A, Walker, A, Ssali, F, Munderi, P, Mambule, I, Kityo, C, Grosskurth, H, Gilks, C, Gibb, D, Hakim, J

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine... by Munderi, P, Walker, A, Kityo, C, Babiker, A, Ssali, F, Reid, A, Darbyshire, J, Grosskurth, H, Mugyenyi, P, Gibb, D, Gilks, C

Pharmacokinetics of lopinavir-ritonavir with and without nonnucleoside reverse transcriptase inhibitors in Ugandan HIV-infected adults. by Kityo, C, Walker, A, Dickinson, L, Lutwama, F, Kayiwa, J, Ssali, F, Nalumenya, R, Tumukunde, D, Munderi, P, Reid, A, Gilks, C, Gibb, D, Khoo, S

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART coh... by Walker, A, Ford, D, Gilks, C, Munderi, P, Ssali, F, Reid, A, Katabira, E, Grosskurth, H, Mugyenyi, P, Hakim, J, Darbyshire, J, Gibb, D, Babiker, A

Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial. by Ssali, F, Stöhr, W, Munderi, P, Reid, A, Walker, A, Gibb, D, Mugyenyi, P, Kityo, C, Grosskurth, H, Hakim, J, Byakwaga, H, Katabira, E, Darbyshire, J, Gilks, C

Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA). by Gilks, C, Walker, A, Dunn, D, Gibb, D, Kikaire, B, Reid, A, Musana, H, Mambule, I, Kasirye, R, Robertson, V, Ssali, F, Spyer, M, Pillay, D, Yirrell, D, Kaleebu, P

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe by Lara, A, Kigozi, J, Amurwon, J, Muchabaiwa, L, Wakaholi, B, Mota, R, Walker, A, Kasirye, R, Ssali, F, Reid, A, Grosskurth, H, Babiker, A, Kityo, C, Katabira, E, Munderi, P, Mugyenyi, P, Hakim, J, Darbyshire, J, Gibb, D, Gilks, C, DARTT Team

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. by Mugyenyi, P, Walker, A, Hakim, J, Munderi, P, Gibb, D, Kityo, C, Reid, A, Grosskurth, H, Darbyshire, J, Ssali, F, Bray, D, Katabira, E, Babiker, A, Gilks, C, Grosskurth, H, Munderi, P, Kabuye, G, Nsibambi, D, Kasirye, R, Zalwango, E, Nakazibwe, M, Kikaire, B, Nassuna, G, Massa, R, Fadhiru, K